Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,644,000 | 1,665,000 | 6,698,000 | 5,762,000 | 3,817,000 |
| Depreciation Amortization | N/A | N/A | 6,175,000 | 4,343,000 | 2,835,000 |
| Income taxes - deferred | N/A | N/A | 1,119,000 | 977,000 | 648,000 |
| Accounts receivable | N/A | N/A | -229,000 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -587,000 | N/A | N/A |
| Other Working Capital | -1,841,000 | -1,698,000 | -2,188,000 | -2,462,000 | -2,362,000 |
| Other Operating Activity | 3,824,000 | 2,078,000 | 487,000 | -736,000 | -285,000 |
| Operating Cash Flow | $5,627,000 | $2,045,000 | $11,475,000 | $7,884,000 | $4,653,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,000 | -15,000 | 92,000 | 89,000 | 34,000 |
| PPE Investments | -660,000 | -335,000 | -1,701,000 | -986,000 | -214,000 |
| Net Acquisitions | -712,000 | -706,000 | -1,513,000 | -1,052,000 | -885,000 |
| Purchase Of Investment | -177,000 | -131,000 | -247,000 | -265,000 | N/A |
| Sale Of Investment | 208,000 | 140,000 | 247,000 | N/A | N/A |
| Purchase Sale Intangibles | -48,000 | -7,000 | -170,000 | -154,000 | -551,000 |
| Other Investing Activity | -90,000 | -54,000 | -319,000 | -154,000 | -551,000 |
| Investing Cash Flow | $-1,438,000 | $-1,101,000 | $-3,441,000 | $-2,368,000 | $-1,616,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,270,000 | 2,304,000 | 1,816,000 | 4,163,000 | 4,081,000 |
| Debt Issued | 4,932,000 | 4,930,000 | 1,935,000 | N/A | N/A |
| Debt Repayment | -187,000 | 0 | -1,696,000 | N/A | N/A |
| Common Stock Issued | N/A | 234,000 | N/A | -690,000 | N/A |
| Common Stock Repurchased | -3,168,000 | -1,292,000 | -1,109,000 | N/A | -280,000 |
| Dividend Paid | -6,482,000 | -6,564,000 | -6,468,000 | -6,475,000 | -6,475,000 |
| Other Financing Activity | 235,000 | 0 | 208,000 | -9,000 | 5,000 |
| Financing Cash Flow | $-3,400,000 | $-388,000 | $-5,314,000 | $-3,011,000 | $-2,669,000 |
| Exchange Rate Effect | 60,000 | 9,000 | -387,000 | -5,000 | -6,000 |
| Beginning Cash Position | 7,007,000 | 7,007,000 | 4,674,000 | 4,674,000 | 4,674,000 |
| End Cash Position | 7,856,000 | 7,572,000 | 7,007,000 | 7,174,000 | 5,036,000 |
| Net Cash Flow | $849,000 | $565,000 | $2,333,000 | $2,500,000 | $362,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,627,000 | 2,045,000 | 11,475,000 | 7,884,000 | 4,653,000 |
| Capital Expenditure | -676,000 | -344,000 | -1,862,000 | -1,276,000 | -833,000 |
| Free Cash Flow | 4,951,000 | 1,701,000 | 9,613,000 | 6,608,000 | 3,820,000 |